Programs & Events

Understanding the HER2 Story in Gastrointestinal Malignancies: A GEA and BTC Focus

Virtual

We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to gain a better understanding of emerging anti-human epidermal growth factor receptor 2 (HER2) therapies used to manage gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC). Register and attend today.

30 Miles in March Challenge

Commit to the 30 miles in March Challenge! Walk, Run, Bike, Hike or Swim 30 miles in the month of March. The challenge begins on March 1st and lasts until March 31st. There is no fee to join the challenge. Participants who raise $30 by March 31st, will earn a blue ALF branded tote bag.

Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma (GEA)

On-Demand

We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to better understand established and emerging data related to HER2-targeted therapies in GEA. This on-demand course is available for continuing education credit until 3/29/25.

cross linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram